H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| Beam Inc. (NASDAQ: BEAM) | Delayed: 23.79 -0.26 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.05 | 52 Week High | $83.60 | |||
| Open | $24.00 | 52 Week Low | $82.96 | |||
| Day High | $24.11 | P/E | 10.62 | |||
| Day Low | $23.65 | EPS | $2.24 | |||
| Volume | 1,401,443 | |||||
